BHWM
RNAM

Beaird Harris Wealth Management’s Avidity Biosciences RNAM Stock Holding History

Beaird Harris Wealth Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-184
Closed -$2.04K – 478
2023
Q2 		$2.04K Hold
184
– – ﹤0.01% 369
2023
Q1 		$2.83K Hold
184
– – ﹤0.01% 354
2022
Q4 		$4.08K Hold
184
– – ﹤0.01% 458
2022
Q3 		$3K Hold
184
– – ﹤0.01% 383
2022
Q2 		$3K Hold
184
– – ﹤0.01% 338
2022
Q1 		$3K Hold
184
– – ﹤0.01% 497
2021
Q4 		$4K Buy
+184
New +$4.39K ﹤0.01% 501

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Beaird Harris Wealth Management's RNAM Position: Q3 2023 in Review

Beaird Harris Wealth Management sold out of Avidity Biosciences (RNAM) in Q3 2023, closing a stake of 184 shares — an estimated $2.04K sold.

Beaird Harris Wealth Management first reported a position in RNAM in Q4 2021 and held it in 7 quarters. The position peaked at $4.08K in Q4 2022. 142 funds tracked by Wall St. Rank hold RNAM as of Q3 2023.

  • Beaird Harris Wealth Management reported no remaining Avidity Biosciences position as of Q3 2023 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 184 Avidity Biosciences shares in Q3 2023, an estimated $2.04K.
  • Beaird Harris Wealth Management first reported a position in Avidity Biosciences in Q4 2021 and held it in 7 quarters.
  • Beaird Harris Wealth Management's Avidity Biosciences position peaked at $4.08K in Q4 2022.
  • 142 funds tracked by Wall St. Rank held Avidity Biosciences as of Q3 2023.

Based on Beaird Harris Wealth Management's 13F filing for Q3 2023, filed 15 Nov 2023.